147 related articles for article (PubMed ID: 3146141)
21. Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits.
Agnelli G; Pascucci C; Colucci M; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1992 Sep; 68(3):331-5. PubMed ID: 1440500
[TBL] [Abstract][Full Text] [Related]
22. A collaborative study to establish a standard for high molecular weight urinary-type plasminogen activator (HMW/u-PA).
Gaffney PJ; Heath AB
Thromb Haemost; 1990 Nov; 64(3):398-401. PubMed ID: 2128969
[TBL] [Abstract][Full Text] [Related]
23. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
Lu HR; Lijnen HR; Stassen JM; Collen D
Blood; 1991 Jul; 78(1):125-31. PubMed ID: 1906351
[TBL] [Abstract][Full Text] [Related]
24. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agents.
Rijken DC; Seifried E; Barrett-Bergshoeff MM; Dooijewaard G
Thromb Haemost; 1990 Aug; 64(1):47-52. PubMed ID: 2125758
[TBL] [Abstract][Full Text] [Related]
26. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
Rahman F
Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
Fischer BE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
[TBL] [Abstract][Full Text] [Related]
28. The contact-system dependent plasminogen activator from human plasma: identification and characterization.
Binnema DJ; Dooijewaard G; van Iersel JJ; Turion PN; Kluft C
Thromb Haemost; 1990 Nov; 64(3):390-7. PubMed ID: 2128968
[TBL] [Abstract][Full Text] [Related]
29. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma.
Declerck PJ; Lijnen HR; Verstreken M; Moreau H; Collen D
Blood; 1990 May; 75(9):1794-800. PubMed ID: 1691934
[TBL] [Abstract][Full Text] [Related]
30. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
Li XK; Lijnen HR; Nelles L; Hu MH; Collen D
Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910
[TBL] [Abstract][Full Text] [Related]
31. Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitro.
Dosne AM; Dubor F; Samama M
Thromb Res; 1991 Sep; 63(5):531-9. PubMed ID: 1755005
[TBL] [Abstract][Full Text] [Related]
32. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
Bode C; Runge MS; Schönermark S; Eberle T; Newell JB; Kübler W; Haber E
Circulation; 1990 Jun; 81(6):1974-80. PubMed ID: 2111744
[TBL] [Abstract][Full Text] [Related]
33. K1K2Pu, a recombinant t-PA/u-PA chimera with increased thrombolytic potency, consisting of amino acids 1 to 3 and 87 to 274 of human tissue-type plasminogen activator (t-PA) and amino acids 138 to 411 of human single chain urokinase-type plasminogen activator (scu-PA). Purification in centigram quantities and conditioning for use in man.
Collen D; Nelles L; De Cock F; Lemmens G; Van Coetsem T; Demarsin E; Lijnen HR
Thromb Res; 1992 Feb; 65(3):421-38. PubMed ID: 1631805
[TBL] [Abstract][Full Text] [Related]
34. Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction.
Köhler M; Sen S; Miyashita C; Hermes R; Pindur G; Heiden M; Berg G; Mörsdorf S; Leipnitz G; Zeppezauer M
Thromb Res; 1991 Apr; 62(1-2):75-81. PubMed ID: 1906642
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase.
Holvoet P; Laroche Y; Lijnen HR; Van Cauwenberge R; Demarsin E; Brouwers E; Matthyssens G; Collen D
J Biol Chem; 1991 Oct; 266(29):19717-24. PubMed ID: 1918077
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
Li XK; Lijnen HR; Nelles L; Van Hoef B; Stassen JM; Collen D
Blood; 1992 Jan; 79(2):417-29. PubMed ID: 1730087
[TBL] [Abstract][Full Text] [Related]
37. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
Lijnen HR; Li XK; Nelles L; Hu MH; Collen D
Eur J Biochem; 1992 Apr; 205(2):701-9. PubMed ID: 1533368
[TBL] [Abstract][Full Text] [Related]
38. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility.
Potter van Loon BJ; Rijken DC; Brommer EJ; van der Maas AP
Thromb Haemost; 1992 Jan; 67(1):101-5. PubMed ID: 1615463
[TBL] [Abstract][Full Text] [Related]
39. [Plasminogen activator inhibitors from neoplastic tissues].
Mirowski M; Wierzbicki R
Postepy Hig Med Dosw; 1991; 45(1-2):119-27. PubMed ID: 1923993
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activation in diabetes mellitus: kinetics of plasmin formation with plasminogen and tissue plasminogen activator from diabetic donors.
Geiger M; Binder BR
Semin Thromb Hemost; 1991 Oct; 17(4):417-21. PubMed ID: 1839461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
